Dear Prof CERASALE MORTEO,
Molecular Cancer invites you to submit to its new thematic series on Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities.
The series will cover all aspects related to expression, regulation and function of receptor tyrosine kinases (RTKs), non-receptor tyrosine kinases and other kinases in oncogenic signaling in cancer cells. Other topics of interest relate to targeted therapies, tyrosine kinase inhibitors (TKI), genetic and epigenetic mechanisms of acquired resistance to TKI, clinical trials and pre-clinical studies.
The deadline for submissions is 15 October 2017. To submit your manuscript, please use Molecular Cancer's online submission system. Please use the 'Additional Information' tab to specify that you are submitting to this series.
Editor-in-Chief, Molecular Cancer
* The Impact Factor (IF) is just one measure used for evaluating the impact of research. For further information on the IF and alternative metrics used to measure the impact of research, please click here.